Excited to hear Mia's talk on RWD and Genomics🧬 at SABCS. Hope to see you in San Antonio!

Congratulations Elsa Anagnostou on this well deserved award! Excited to see where you take the field next 😝

This gives me chills Pashtoon Kasi MD, MS and really showcases why a precision medicine approach🧬 is so important. Moving and educational story. Thank you for all you do!

Beautiful work! Congrats Shilpa Gupta Ben Miron

Umberto Malapelle Yakup Ergün Umut. Dişel Oncology Brothers Paolo Tarantino Bijoy Telivala Santhosh Ambika Sara Tolaney Giampaolo Bianchini International Society of Liquid Biopsy There are more evidence of LB ctDNA TF utility to increase detection of molecular alterations across tumors. Two examples: the data we presented in #ASCO23 with Geoff Oxnard MD Hatim Husain ascopubs.org/doi/abs/10.120… International Society of Liquid Biopsy

Umberto Malapelle Yakup Ergün Umut. Dişel Oncology Brothers Paolo Tarantino Bijoy Telivala Santhosh Ambika Sara Tolaney Giampaolo Bianchini International Society of Liquid Biopsy Geoff Oxnard MD Hatim Husain Another nice paper including PIK3CA in breast sensitivity increased in TF high ascopubs.org/doi/pdfdirect/… Hatim Husain Geoff Oxnard MD International Society of Liquid Biopsy

Looking forward to seeing everyone in Chicago! The countdown has begun :) lnkd.in/gJfXqus8

Two new studies at ASCO #GI23 , feature research on predictive biomarkers and genomic alterations, using real-world data from patients with metastatic colorectal cancer (mCRC). Learn more about this #NewResearch and poster session: bit.ly/3QNy5T7

👀 Check out what’s popular this week in #JCOPO :

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study 👉 fal.cn/3tl9d The ICR #ctDNA #Sarcoma #pedcsm

#NewResearch in JCO Precision Oncology studied the relationship between circulating tumor DNA (ctDNA) shed and detection of actionable biomarkers in liquid biopsy-based genomic profiling across 23,000 specimens. Learn more about the findings of this study: bit.ly/3N2yT4m

Great presentation on detecting fusions using liquid biopsy by Dr. ⁦Pashtoon Kasi MD, MS⁩ #ISLB22 . ⁦Christine Lovly, MD, PhD⁩

Excited to join #LiquidBiopsy experts at this year’s International Society of Liquid Biopsy 2022 Congress where we will be sharing new #research featuring the latest advancements in liquid biopsy-based comprehensive genomic profiling. Learn more about #ISLB2022 : bit.ly/3Vh3f74

Come learn with us! 📚

Congrats Umang Swami and Foundation Medicine collaborators on this impactful and innovative science! Important finding 👏 for prostate cancer patients and their treating physicians.

We’re joining others from Adaptive Biotech & Center for Gastrointestinal Cancers for a workshop MAPS about increasing gender equity in advisory boards. The session will define the observed gaps and share practical tips for addressing this disparity. Read more: bit.ly/3q9TN7L

To my hem/onc colleagues: besides EHA, ASH and ASCO, what are some other 'can't miss' liquid tumor conferences with an international focus?

This is why there is urgency in the work we do: harpers.org/archive/2017/0… via Harper's Magazine

Abiraterone +ADT v ADT for 1st line #ProstateCancer NEJM #ASCO17 STAMPEDE: 9000 pts 3000 study staff #teamscience nejm.org/doi/full/10.10…

One of the most important messages from Dr. Brian Ducker: 'precision early detection and TREAT EARLY DURING THE DISEASE' #ASCO17 The ASCO Post

Tremendous need for effective ways to determine who will respond to PARP inhibitor therapy. More: bit.ly/2pKhnrd #ovariancancer